Martine Rothblatt | Founder, Chairman & CEO |
Andrew Fisher | Deputy General Counsel and Chief Strategy Officer |
Alethia Young | Crédit Suisse AG |
Evan Seigerman | Barclays PLC |
Santhosh Palani | Cowen and Company |
Jessica Fye | JPMorgan Chase & Co. |
Hartaj Singh | Oppenheimer & Co. |
Good morning. My name is Andrew, and I will be your conference operator today. At this time, I would like to welcome everyone to the United Therapeutics Corporation 2017 Third Quarter Financial Results. [Operator Instructions]. Remarks today concerning United Therapeutics will include forward-looking statements representing the company's expectations or beliefs regarding future events.